Pfizer. Vaccine. LFG.

Published|Updated

Pfizer announced today that a COVID-19 vaccine that they have been developing in collaboration with BioNTech was found in a Phase 3, late-stage study "to be more than 90% effective in preventing COVID-19 in participants without evidence of prior SARS-CoV-2 infection in the first interim efficacy analysis."

Pfizer's CEO went on CNBC and said that over a billion doses will be available in 2021:






Unsurprisingly, stock futures (except for companies that benefit from lockdowns, like Zoom, which is down about 12% pre-market), are up big today. S&P futures are up over 4%, and Dow futures are up nearly 6%.

This is some great news that, hopefully, the world will be approaching a normal place by next summer.



Tags
Written by
Ryan Glasspiegel grew up in Connecticut, graduated from University of Wisconsin-Madison, and lives in Chicago. Before OutKick, he wrote for Sports Illustrated and The Big Lead. He enjoys expensive bourbon and cheap beer.